Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: A study of 24 patients

Neuropediatrics

Volumn 36, Issue 1, 2005, Pages 21-34

  Ruggieri, Martino ^a,b   Iannetti, P ^c   Polizzi, A ^b   La Mantia, I ^b   Spalice, A ^c   Giliberto, O ^d   Platania, N ^b   Gabriele, A L ^a   Albanese, V ^b   Pavone, L ^b  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d CANNIZZARO HOSPITAL   (Italy)

Author keywords

Early onset; Neurofibromatosis; NF2; Paediatric

Indexed keywords

ACOUSTIC NEURINOMA; ADOLESCENT; ADULT; AMBLYOPIA; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN STEM TUMOR; CAFE AU LAIT SPOT; CATARACT; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CRANIAL NERVE; CRANIAL NEUROPATHY; DISEASE ACTIVITY; DISEASE COURSE; EAR INFECTION; EYE DISEASE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEARING LOSS; HOARSENESS; HUMAN; HUMAN TISSUE; ITALY; MALE; MENINGIOMA; MOLECULAR GENETICS; NERVOUS SYSTEM TUMOR; NEUROFIBROMATOSIS; NEUROLOGIC DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEIZURE; SKIN TUMOR; STRABISMUS; TINNITUS; BRAIN; COMPARATIVE STUDY; EAR NOSE THROAT DISEASE; EYE MOVEMENT DISORDER; FAMILY HEALTH; FOLLOW UP; GENETICS; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SPINAL CORD;

ADOLESCENT; ADULT; BRAIN; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVOUS SYSTEM DISEASES; NEUROFIBROMATOSIS 2; OCULAR MOTILITY DISORDERS; OTORHINOLARYNGOLOGIC DISEASES; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SPINAL CORD;

EID: 21044447532     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-837581     Document Type: Article

References (26)

1. Baser ME, Friedman JM, Wallace AJ, Ramsden RT, Joe H, Evans DG et al. Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology 2002; 59: 1759-1765
2. Baser ME, Evans DGR, Gutmann DH. Neurofibromatosis 2. Curr Opin Neurol 2003; 16: 27-33
3. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton W et al. A clinical study of type 2 neurofibromatosis. Q. J Med J 1992; 304: 603-618
4. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Teare D et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. I: Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 1992; 29: 841-846
5. Evans DGR, Trueman L, Wallace A, Collins S, Strachan T. Genotype/phenotype correlation in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet 1998; 35: 450-455
6. Evans DGR, Birch JM, Ramsden RT. Paediatric presentation of type 2 neurofibromatosis. Arch Dis Child 1999; 81: 496-499
7. Evans DGE, Sainio M, Baser ME. Neurofibromatosis type 2. J Med Genet 2000; 37: 897-904
8. Friedman J, Gutmann DH, MacCollin M, Riccardi VM. Neurofibromatosis: Phenotype, Natural History and Pathogenesis. 3rd ed. Baltimore, London: Johns Hopkins University Press, 1999
9. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997; 278: 51-53
10. Health supervision for children with neurofibromatosis. American Academy of Pediatrics Committee on Genetics. Pediatrics 1995; 92: 368-372
11. Huson SM, Hughes RAC. The Neurofibromatoses. A Pathogenetic and Clinical Overview. London: Churchill Livingstone, 1994
12. Huson SM, Ruggieri M. The neurofibromatoses. In: Harper J, Oranje JM, Rose M (eds). Pediatric Dermatology. Oxford: Blackwell Science, 2000: 1204-1224
13. MacCollin M, Bove C, Kluwe L, Ojemann R, Mautner VF. The natural history of neurofibromatosis 2 in 31 affected children. Ann Neurol 1996; 44: A576
14. MacCollin M, Mautner VF. The diagnosis and management of neurofibromatosis type 2 in childhood. Semin Pediatr Neurol 1998; 5: 243-252
15. Mautner VF, Tatagiba M, Guthoff R, Samili M, Pulst SM. Neurofibromatosis type 2 in the paediatric age group. Neurosurgery 1993; 33: 92-96
16. Mautner VF, Baser ME, Takkar SD, Feigen UM, Friedman JM, Kluwe L Vestibular schwannoma growth in patients with neurofibromatosis type 2: a longitudinal study. J Neurosurg 2002; 96: 223-228
17. Mautner VF, Lindenau M, Baser ME, Kluwe L, Gottschalk J. Skin abnormalities in neurofibromatosis type 2. Arch Dermatol 1997; 133: 1539-1543
18. National Institutes of Health Consensus Development Conference Statement. Neurofibromatosis. Arch Neurol 1988; 45: 575-578
19. National Institutes of Health Consensus Development Conference Statement. Acoustic neuromas. Arch Neurol 1994; 51: 201-207
20. Nunes F, MacCollin M. Neurofibromatosis type 1 in the pediatric population. J Child Neurol 2002; 18: 718-724
21. Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N. Neurofibromatosis type 2 (NF2): Clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 1994; 52: 450-461
22. Pediatric Committee. Pediatric audiologic profile in type 1 and type 2 neurofibromatosis. J Am Acad Audiol 1995; 6: 54-62
23. Ragge NK, Baser ME, Klein J, Nchiparul A, Sainza J, Pulst JM et al. Ocular abnormalities in neurofibromatosis 2. Am J Ophthalmol 1995; 120: 634-641
24. Ruggieri M. The different forms of neurofibromatosis. Child's Nerv Syst 1999; 15: 295-308
25. Ruggieri M, Huson SM. Clinical presentations of neurofibromatosis type 2 in childhood. Eur J Pediatr Neurol 1999; 3: A66
26. Ruggieri M, Huson S. The clinical and diagnostic implications of mosaicism in the neurofibromatosis. Neurology 2001; 56: 1433-1443